Whole exome sequencing reveals a novel LRBA mutation and clonal hematopoiesis in a common variable immunodeficiency patient presented with hemophagocytic lymphohistiocytosis.

Experimental Hematology & Oncology
Yanling RenHongyan Tong

Abstract

Common variable immunodeficiency (CVID) was a kind of primary immunodeficiency disorders with heterogeneous phenotype and genotype. Lipopolysaccharide-responsive and beige-like anchor (LRBA) mutation was identified as disease associated in CVID, advanced genetic method will help to detect atypical cases. We report a case of adult patient manifested as hemophagocytic lymphohistiocytosis (HLH), bone marrow examination suggested prosperity to MDS, manifested as increased immature myeloid cells and dysplastic hematopoiesis. Whole exome sequencing (WES) identified a novel heterogeneous c.1876T > C (p.W626R) mutation in LRBA and four somatic mutations: ASXL1 (c.1967dupA); PTPN11 (c.226G > A), U2AF1 (c.101C > T and c.470A > G), among which ASXL1 was a high-risk marker of clonal hematopoiesis. Combined with her recurrent severe infections and immune abnormalities such as hypoimmunoglobulinemia, the patient was diagnosed with CVID. Subsequent hematopoietic stem cell transplantation saved her from severe cytopenia and immune deficiency. This case report highlights the great promise of utilization of WES for diagnosing rare disease with atypical manifestations and guiding further treatment.

References

May 23, 2012·American Journal of Human Genetics·Gabriela Lopez-HerreraBodo Grimbacher
Jul 1, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Pauline A van SchouwenburgSmita Y Patel
Jan 16, 2016·The Journal of Allergy and Clinical Immunology·Laura Gámez-DíazBodo Grimbacher
Jun 14, 2017·The Journal of Allergy and Clinical Immunology·Paul C MayorBrahm H Segal
Aug 15, 2017·Pediatric Annals·Ysabella M EstebanMelissa S Tesher
Feb 19, 2019·The Journal of Allergy and Clinical Immunology. in Practice·Markus G SeidelUNKNOWN ESID Registry Working Party and collaborators
Jul 3, 2019·Scientific Reports·Magnhild E MacphersonSilje F Jørgensen
Jan 17, 2020·Blood·Hassan AbolhassaniCharlotte Cunningham-Rundles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.